BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33596974)

  • 21. Adjuvant radiotherapy in grossly total resected grade II atypical meningiomas: a protective effect on recurrence?
    Zoli M; Della Pepa GM; Carretta A; Bongetta D; Somma T; Zoia C; Raffa G
    J Neurosurg Sci; 2022 Jun; 66(3):240-250. PubMed ID: 34763391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
    Ren L; Cheng H; Chen J; Deng J; Wang D; Xie Q; Wakimoto H; Hua L; Gong Y
    J Neurosurg; 2023 Jul; 139(1):49-58. PubMed ID: 36334291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
    Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
    World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.
    Anakwenze CP; McGovern S; Taku N; Liao K; Boyce-Fappiano DR; Kamiya-Matsuoka C; Ghia A; Chung C; Trifiletti D; Ferguson SD; Li J; Yeboa DN
    World Neurosurg; 2020 Sep; 141():e133-e144. PubMed ID: 32407910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.
    Phonwijit L; Khawprapa C; Sitthinamsuwan B
    World Neurosurg; 2017 Nov; 107():698-705. PubMed ID: 28838877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
    Aizer AA; Arvold ND; Catalano P; Claus EB; Golby AJ; Johnson MD; Al-Mefty O; Wen PY; Reardon DA; Lee EQ; Nayak L; Rinne ML; Beroukhim R; Weiss SE; Ramkissoon SH; Abedalthagafi M; Santagata S; Dunn IF; Alexander BM
    Neuro Oncol; 2014 Nov; 16(11):1547-53. PubMed ID: 24891451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
    Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
    World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma.
    Anand SK; Sardari H; Sadeghsalehi A; Bagheri SR; Eden SV; Lawton MT; Alimohammadi E
    Neurol Res; 2022 May; 44(5):468-474. PubMed ID: 34967283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
    Weber DC; Ares C; Villa S; Peerdeman SM; Renard L; Baumert BG; Lucas A; Veninga T; Pica A; Jefferies S; Ricardi U; Miralbell R; Stelmes JJ; Liu Y; Collette L; Collette S
    Radiother Oncol; 2018 Aug; 128(2):260-265. PubMed ID: 29960684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
    Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
    Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
    Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
    J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
    Sun SQ; Kim AH; Cai C; Murphy RK; DeWees T; Sylvester P; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Leonard JR; Evans J; Simpson JR; Robinson CG; Perrin RJ; Huang J; Chicoine MR
    Neurosurgery; 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355. PubMed ID: 24932707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection.
    Loewenstern J; Shuman W; Rutland JW; Kessler RA; Kohli KM; Umphlett M; Pain M; Bederson J; Fowkes M; Shrivastava RK
    World Neurosurg; 2019 Aug; 128():e148-e156. PubMed ID: 30995555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
    Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
    World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Postoperative Radiotherapy in Patients with Atypical Meningiomas After Gross Total Resection: Analysis of 260 Cases.
    Zeng Q; Tian Z; Gao Q; Xu P; Shi F; Zhang J; Guo Z
    World Neurosurg; 2022 Jun; 162():e580-e586. PubMed ID: 35307589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant radiotherapy for atypical meningiomas is associated with improved progression free survival.
    Unterberger A; Ng E; Pradhan A; Kondajji A; Kulinich D; Duong C; Yang I
    J Neurol Sci; 2021 Sep; 428():117590. PubMed ID: 34358821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major complications from radiotherapy following treatment for atypical meningiomas.
    Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
    Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.